These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1769281)

  • 1. Bethesda System of reporting: a Canadian viewpoint.
    Anderson G
    Diagn Cytopathol; 1991; 7(6):559-61. PubMed ID: 1769281
    [No Abstract]   [Full Text] [Related]  

  • 2. The Bethesda system for the reporting of cervical/vaginal cytology.
    Oren A; Fernandes J
    J Am Osteopath Assoc; 1991 May; 91(5):476-9. PubMed ID: 2061103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop.
    JAMA; 1989 Aug; 262(7):931-4. PubMed ID: 2754794
    [No Abstract]   [Full Text] [Related]  

  • 4. The Bethesda system for classification of Pap smears: the clinical experience of one cancer screening center.
    Mahon SM
    Cancer Nurs; 1995 Dec; 18(6):458-66. PubMed ID: 8564942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing abnormal Pap smears: comments on two articles.
    Buck HW
    J Am Coll Health; 1989 Sep; 38(2):101-2. PubMed ID: 2778225
    [No Abstract]   [Full Text] [Related]  

  • 6. [New classification in cervical cytology: the Bethesda system].
    Bodó M; Tóth V
    Orv Hetil; 1991 May; 132(19):1039-40. PubMed ID: 2027678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cervical cytology.
    Beal MW
    NAACOGS Clin Issu Perinat Womens Health Nurs; 1990; 1(4):470-8. PubMed ID: 2081083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pap smear update--the Bethesda (nomenclature) System.
    Piper DM
    West J Med; 1991 Mar; 154(3):325. PubMed ID: 2028595
    [No Abstract]   [Full Text] [Related]  

  • 9. The 1988 Bethesda system for cervical vaginal cytology: pros and cons.
    Barlow JF
    S D J Med; 1991 Jun; 44(6):157-8. PubMed ID: 1658929
    [No Abstract]   [Full Text] [Related]  

  • 10. The pitfalls of cervical cancer screening.
    Sedlis A
    Contrib Gynecol Obstet; 1991; 18():103-14. PubMed ID: 1657521
    [No Abstract]   [Full Text] [Related]  

  • 11. [Is Bethesda system better than Pap classification?].
    Vuopala S
    Duodecim; 1999; 115(18):2030-4. PubMed ID: 11941821
    [No Abstract]   [Full Text] [Related]  

  • 12. Cervical cancer screening--an alternative viewpoint.
    Rogers A
    West Engl Med J; 1990 Sep; 105(3):77-9, 71. PubMed ID: 2093353
    [No Abstract]   [Full Text] [Related]  

  • 13. The Bethesda system and Pap smear screening.
    Miller K
    Am Fam Physician; 1995 Feb; 51(2):331-2. PubMed ID: 7840027
    [No Abstract]   [Full Text] [Related]  

  • 14. The Bethesda system for cervical/vaginal cytologic diagnoses.
    Herbst AL
    Clin Obstet Gynecol; 1992 Mar; 35(1):22-7. PubMed ID: 1544245
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: Cervical cancer screening programs: a gynecologist's viewpoint.
    Popkin DR
    Can Med Assoc J; 1976 Jun; 114(11):982, 984. PubMed ID: 1277030
    [No Abstract]   [Full Text] [Related]  

  • 16. The Bethesda System and patient management strategies.
    Helmuth RA; Moriarty AT; Schwenk GR
    Indiana Med; 1992; 85(6):500-3. PubMed ID: 1431035
    [No Abstract]   [Full Text] [Related]  

  • 17. Back to the negative Pap test: behind the scenes at Bethesda 2001.
    Young NA
    Diagn Cytopathol; 2002 Apr; 26(4):207-8. PubMed ID: 11933263
    [No Abstract]   [Full Text] [Related]  

  • 18. The Bethesda System for reporting cervical/vaginal cytologic diagnoses. Report of the 1991 Bethesda Workshop.
    Am J Surg Pathol; 1992 Sep; 16(9):914-6. PubMed ID: 1415910
    [No Abstract]   [Full Text] [Related]  

  • 19. Pap smears are financially undervalued in the United States.
    Herbert A
    Hum Pathol; 1997 Oct; 28(10):1218. PubMed ID: 9343333
    [No Abstract]   [Full Text] [Related]  

  • 20. [Protocol following the evaluation of Pap class IIIA in mass screening for cervix carcinoma].
    Appelman CL; Pal RS
    Ned Tijdschr Geneeskd; 1986 Oct; 130(41):1844-7. PubMed ID: 3785448
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.